Headquarters: Dijon, France
CEO: Mr. Patrick Alexandre
EUR as of July 1, 2023
|Company||Market Cap (USD)|
|Intuitive Surgical, Inc.||$116.08 B|
|EssilorLuxottica SA||$84.47 B|
|Becton, Dickinson and Company||$73.65 B|
|Alcon Inc.||$40.22 B|
|HOYA Corp||$39.96 B|
Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of overdose; Apomorphine, for treating temporary paralysis in parkinson's disease; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. The company was founded in 1997 and is based in Dijon, France.
Unlock the Power of Financial AI:
Try Disfold AI Free for 7 Days!